• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多模态刺激筛选揭示了限制 T 细胞适应性的独特和共享基因。

Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness.

机构信息

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Tumor Immunology and Immunotherapy Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain.

出版信息

Cancer Cell. 2024 Apr 8;42(4):623-645.e10. doi: 10.1016/j.ccell.2024.02.016. Epub 2024 Mar 14.

DOI:10.1016/j.ccell.2024.02.016
PMID:38490212
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11003465/
Abstract

Genes limiting T cell antitumor activity may serve as therapeutic targets. It has not been systematically studied whether there are regulators that uniquely or broadly contribute to T cell fitness. We perform genome-scale CRISPR-Cas9 knockout screens in primary CD8 T cells to uncover genes negatively impacting fitness upon three modes of stimulation: (1) intense, triggering activation-induced cell death (AICD); (2) acute, triggering expansion; (3) chronic, causing dysfunction. Besides established regulators, we uncover genes controlling T cell fitness either specifically or commonly upon differential stimulation. Dap5 ablation, ranking highly in all three screens, increases translation while enhancing tumor killing. Loss of Icam1-mediated homotypic T cell clustering amplifies cell expansion and effector functions after both acute and intense stimulation. Lastly, Ctbp1 inactivation induces functional T cell persistence exclusively upon chronic stimulation. Our results functionally annotate fitness regulators based on their unique or shared contribution to traits limiting T cell antitumor activity.

摘要

限制 T 细胞抗肿瘤活性的基因可能成为治疗靶点。目前尚未系统研究是否存在独特或广泛影响 T 细胞适应性的调节剂。我们在原代 CD8 T 细胞中进行了全基因组规模的 CRISPR-Cas9 敲除筛选,以发现三种刺激模式(1)强烈,引发激活诱导的细胞死亡(AICD);(2)急性,引发扩增;(3)慢性,导致功能障碍)对适应性有负面影响的基因。除了已建立的调节剂外,我们还发现了在不同刺激下特异性或共同控制 T 细胞适应性的基因。Dap5 缺失在所有三种筛选中排名都很高,它在提高翻译的同时增强了肿瘤杀伤能力。在急性和强烈刺激后,丧失 Icam1 介导的同种型 T 细胞聚集作用会增强细胞扩增和效应功能。最后,Ctbp1 失活仅在慢性刺激时诱导功能 T 细胞的持久性。我们的结果根据它们对限制 T 细胞抗肿瘤活性的特性的独特或共同贡献,对适应性调节剂进行了功能注释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/b227c6bd5db7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/1464a880094f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/7a49216a5cac/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/0b40b253f3aa/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/be46f5ac8be8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/3e21063aaa0c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/e069132afbd0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/b227c6bd5db7/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/1464a880094f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/7a49216a5cac/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/0b40b253f3aa/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/be46f5ac8be8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/3e21063aaa0c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/e069132afbd0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00cf/11003465/b227c6bd5db7/gr6.jpg

相似文献

1
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness.多模态刺激筛选揭示了限制 T 细胞适应性的独特和共享基因。
Cancer Cell. 2024 Apr 8;42(4):623-645.e10. doi: 10.1016/j.ccell.2024.02.016. Epub 2024 Mar 14.
2
Genome-wide fitness gene identification reveals Roquin as a potent suppressor of CD8 T cell expansion and anti-tumor immunity.全基因组适应性基因鉴定揭示 Roquin 是抑制 CD8 T 细胞扩增和抗肿瘤免疫的有效抑制剂。
Cell Rep. 2021 Dec 7;37(10):110083. doi: 10.1016/j.celrep.2021.110083.
3
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.全基因组 CRISPR 筛选在原代人 T 细胞中揭示了免疫功能的关键调节因子。
Cell. 2018 Dec 13;175(7):1958-1971.e15. doi: 10.1016/j.cell.2018.10.024. Epub 2018 Nov 15.
4
Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance.平行 CRISPR-Cas9 筛选阐明了 p53 对筛选性能的影响。
Elife. 2020 May 22;9:e55325. doi: 10.7554/eLife.55325.
5
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells.利用 CD8 T 细胞全基因组体内 CRISPR 筛选进行系统免疫治疗靶标发现。
Cell. 2019 Aug 22;178(5):1189-1204.e23. doi: 10.1016/j.cell.2019.07.044.
6
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence.全基因组 CRISPR 筛选 T 细胞耗竭鉴定出限制 T 细胞持久性的染色质重塑因子。
Cancer Cell. 2022 Jul 11;40(7):768-786.e7. doi: 10.1016/j.ccell.2022.06.001. Epub 2022 Jun 23.
7
Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanoma.CRISPR-Cas9 筛选分析鉴定黑色素瘤中的遗传依赖性。
Pigment Cell Melanoma Res. 2021 Jan;34(1):122-131. doi: 10.1111/pcmr.12919. Epub 2020 Sep 7.
8
Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in monogenic Cas9 knockout screens.多重iplex Cas12a 筛选检测到在单基因 Cas9 敲除筛选中被掩盖的旁系同源物之间的功能缓冲。
Genome Biol. 2020 Oct 15;21(1):262. doi: 10.1186/s13059-020-02173-2.
9
Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal.部分基因抑制可改善 CRISPR-Cas9 基因敲除泛致死时癌症脆弱性鉴定。
Genome Biol. 2023 Aug 23;24(1):192. doi: 10.1186/s13059-023-03020-w.
10
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators.将全基因组 CRISPR 免疫筛选与多组学临床数据相结合,揭示了肿瘤内在免疫调节因子的不同类别。
J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001819.

引用本文的文献

1
CRISPRi Screening Identifies SON and MAP4K1 as Regulators of Type III Cytokine Expression in Innate Lymphoid Cells.CRISPR干扰筛选确定SON和MAP4K1为天然淋巴细胞中III型细胞因子表达的调节因子。
bioRxiv. 2025 Aug 15:2025.08.15.670561. doi: 10.1101/2025.08.15.670561.
2
Enhanced anti-tumor activity by zinc finger repressor-driven epigenetic silencing of immune checkpoints and TGFBR2 in CAR-T cells and TILs.通过锌指阻遏物驱动的免疫检查点和CAR-T细胞及肿瘤浸润淋巴细胞中TGFBR2的表观遗传沉默增强抗肿瘤活性。
Mol Ther Oncol. 2025 May 7;33(2):200989. doi: 10.1016/j.omton.2025.200989. eCollection 2025 Jun 18.
3
Pyruvate kinase M2 activation reprograms mitochondria in CD8 T cells, enhancing effector functions and efficacy of anti-PD1 therapy.

本文引用的文献

1
Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer.单细胞 CRISPR 筛选体内图谱揭示癌症中 T 细胞命运调控网络。
Nature. 2023 Dec;624(7990):154-163. doi: 10.1038/s41586-023-06733-x. Epub 2023 Nov 15.
2
In vitro modeling of CD8 T cell exhaustion enables CRISPR screening to reveal a role for BHLHE40.体外构建 CD8 T 细胞耗竭模型可实现 CRISPR 筛选,从而揭示 BHLHE40 的作用。
Sci Immunol. 2023 Aug 25;8(86):eade3369. doi: 10.1126/sciimmunol.ade3369. Epub 2023 Aug 18.
3
The SWI/SNF chromatin remodeling complexes BAF and PBAF differentially regulate epigenetic transitions in exhausted CD8 T cells.
丙酮酸激酶M2激活可重编程CD8 T细胞中的线粒体,增强效应功能及抗PD1治疗的疗效。
Cell Metab. 2025 Jun 3;37(6):1294-1310.e7. doi: 10.1016/j.cmet.2025.03.003. Epub 2025 Apr 7.
SWI/SNF 染色质重塑复合物 BAF 和 PBAF 差异调节耗竭的 CD8 T 细胞中的表观遗传转变。
Immunity. 2023 Jun 13;56(6):1320-1340.e10. doi: 10.1016/j.immuni.2023.05.008.
4
T-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models.T 样 CAR-T 细胞在临床前模型中比传统 CAR-T 细胞表现出更好的持久性和肿瘤控制效果。
Sci Transl Med. 2023 Apr 5;15(690):eabk1900. doi: 10.1126/scitranslmed.abk1900.
5
Modulating the proliferative and cytotoxic properties of patient-derived TIL by a synthetic immune niche of immobilized CCL21 and ICAM1.通过固定化CCL21和ICAM1的合成免疫微环境调节患者来源的肿瘤浸润淋巴细胞的增殖和细胞毒性特性。
Front Oncol. 2023 Mar 3;13:1116328. doi: 10.3389/fonc.2023.1116328. eCollection 2023.
6
The Gene Ontology knowledgebase in 2023.2023 版基因本体论知识库。
Genetics. 2023 May 4;224(1). doi: 10.1093/genetics/iyad031.
7
Systematic Review on CAR-T Cell Clinical Trials Up to 2022: Academic Center Input.截至2022年的嵌合抗原受体T细胞(CAR-T)临床试验系统评价:学术中心的贡献
Cancers (Basel). 2023 Feb 4;15(4):1003. doi: 10.3390/cancers15041003.
8
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy.删除 SNX9 可减轻 CD8 T 细胞衰竭,从而有效进行细胞癌症免疫治疗。
Nat Commun. 2023 Feb 2;14(1):86. doi: 10.1038/s41467-022-35583-w.
9
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling.TSC2 通过调控 mTOR 信号来调节肿瘤对 TRAIL 介导的 T 细胞杀伤的敏感性。
EMBO J. 2023 Mar 1;42(5):e111614. doi: 10.15252/embj.2022111614. Epub 2023 Jan 30.
10
MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistance.MeVa2.1.dOVA和MeVa2.2.dOVA:两种用于研究肿瘤免疫抗性的新型BRAFV600E驱动的小鼠黑色素瘤细胞系。
Melanoma Res. 2023 Feb 1;33(1):12-26. doi: 10.1097/CMR.0000000000000863. Epub 2022 Dec 20.